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The object of research in the exploration of new chemotherapy agents is to kill
cancerous cells and not harm the healthy cells. In addition, an effective dose of
these agents is essential in conducting clinical studies in the treatment of
cancer. In this study, an investigation of the anticancer effects of a group of
synthetic compounds on human glioma cell lines was carried out. Initially, 11
compounds were screened using cytotoxicity assays. The most active
compounds were found to be derived from bis (S-methyl-I3-N-(2-acetylfuran)
dithiocarbazate) (SMDB) and bis (S-benzyl-I3-N-(2-acetylfuran) dithiocarbazate)
(SBD4) complexed with zinc, cadmium and platinum ions. The glioma cell lines,
A172, U87MG and T98G and normal brain cell line HCN-2, were used in this
study. The ICso values of the cell lines treated with the compounds were
determined by using (3-4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium
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bromide (MTT) assay. Tamoxifen was used as a control as it is the current drug
of choice in the treatment of brain cancer.
From the cytotoxicity assays, it was found that the compounds which showed
the most potential are SMDB-Cd and SMDB-Zn. The ICso values for SMDB-Cd
on A172, U87MG, T98G and HCN-2 were O.65IJg/ml, O.29IJg/ml, OAlJg/ml, and
1AlJg/ml, while that for SMDB-Zn were at 3.7IJg/ml, 1.76IJg/ml, 2.71Jg/ml and
7lJg/ml, respectively. The ICso values for tamoxifen for the same cell lines were
6.7IJg/ml, 5.3IJg/ml, 6.31Jg/ml and 6IJg/ml respectively.
Several methods were employed towards understanding the mechanism of
action at the molecular level for SMDB-Cd and SMDB-Zn on glioma cell lines.
Tunel assay displayed the typical morphological features of apoptosis cells with
condensed and fragmented nuclei at 48 hours. The percentage of apoptotic cells
in all treated cells with tamoxifen, SMDB-Zn and SMDB-Cd were significantly
(p<O.05) increased.
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) was used in
monitoring the gene expression level of two key genes, Epidermal Growth
Factor Receptor (EGFR) and Mouse Double Minute 2 (MDM2). The expression
of EGFR gene was suppressed in all three-cell lines. However, MDM2 gene was
suppressed only in A172 and T98G. Therefore, the suppression of EGFR and
MDM2 by the compounds was one of the pathways to apoptosis in the glioma
cells.
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In the flow cytometry analysis, the effect of SMDB-Cd and tamoxifen on the cell
cycle after 3, 6, 12 and 24 hr treatment showed glioma cells A172, U87MG and
T98G were arrested in G1 phase and the SMDB-Zn arrested glioma cell lines
U87MG, T98G and A172 in, G2/M, S phase and G1 phase, respectively.
The SMDB-Cd and tamoxifen arrested the cell cycle by preventing replication
(phase specific G1 ) whereas SMDB-Zn was not phase specific which can arrest
the cell at any point in the cell cycle.
Results, of caspase-8/9 activity assay of tamoxifen, SMDB-Cd and SMDB-Zn on
glioma cells showed that caspase-8 activity was significantly induced but no
significant activity for caspase-9 was observed. Therefore, the activation of
caspase-8 may be the mechanism through which tamoxifen, SMDB-Cd and
SMDB-Zn induces apoptosis.
The comet assay used to study the genotoxic activity of SMDB-Cd and SMDB-
Zn in CHO cell line showed no genotoxic activity in both compounds. In
conclusion, the two compounds have the potential to be developed as
chemotherapeutic agents.
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Nilai ICso untuk sel-sel tersebut yang telah dirawat dengan sebatian-sebatian
di-atas dipastikan dengan menggunakan kaedah (3-4, 5-dimethylthiazol-2-yl)-2-
5-diphenyltetrazolium bromide (MIT). Tamoksifen telah digunakan sebagai
kawalan memandangkan ia adalah dadah pilihan semasa dalam rawatan kanser
otak.
Dari kaedah sitotoksik itu sebatian-sebatian yang ditemui menunjukkan potensi
adalah SMDB-Cd dan SMDB-Zn. Nilai ICso untuk SMDB-Cd pada A172,
U87MG, T98G dan HCN-2 adalah O.65IJg/ml, O.29IJg/ml, OAlJg/ml, dan
1.4lJg/ml, sementara itu bagi SMDB-Zn adalah 3.7IJg/ml, 1.76IJg/ml, 2.7IJg/ml
and 7lJg/ml. Nilai ICso bagi tamoksifen pula untuk sel-sel yang sama tersebut
adalah 6.7IJg/ml, 5.3IJg/ml, 6.3IJg/ml and 6lJg/ml.
Beberapa kaedah telah dijalankan ke arah memahami mekanisme tindakan
SMDB-Cd dan SMDB-Zn tersebut dalam sel-sel glioma pada peringkat molekul.
Kaedah Tunel telah menunjukkan ciri-ciri morfologi yang tipikal bagi sel-sel
apoptotik dengan nukleusnya yang menjadi padat dan pecah pada 48 jam,
peratus sel-sel yang apoptotik dalam semua sel-sel yang dirawat bersama
tamoxifen, SMDB-Zn dan SMDB-Cd adalah sangat bermakna (p<O.05).
"Reverse Transcription-Polymerase Chain Reaction" (RT-PCR) telah digunakan
dalam pemerhatian paras ekspresi gen terhadap dua gen ini, "Epidermal Growth
Factor Receptor" (EGFR) dan Mouse Double Minute 2 (MDM2). Ekspresi gen
EGFR telah dihalang didalam ketiga-tiga sel yang digunakan.
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CHAPTER 1
INTRODUCTION
1.1 General Background
Cancer is one of the three main causes of death among the economically
active population. The two other main causes of mortality worldwide are
accidents and cardiovascular diseases. Annually, there are more than 6
million deaths from a type of malignant neoplasia worldwide (Tovar-Guzman
ef al., 2001). The number of new cancer cases has been increasing over the
past nine decades. The Malaysian Ministry of Health (1995) reported that
malignant neoplasm is the major cause of death in government hospitals
(45%), which is 2.8 times higher than heart diseases (16%). A total 26,089 of
cancers were diagnosed among all residents in Peninsular Malaysia in the
year 2002, comprising 11,815 males and 14,274 females. An estimated
10,000 cases were however, not registered. In terms of risk, 1 in 5.5
Malaysians can be expected to get cancer in his/her lifetime. Taking into
accounts unregistered cases, the risk would be 1 in 4 Malaysians. The crude
rate for all cancers in the year 2002 was 118.9 per 100,000 males and 148.4
per 100,000 females. (Lim ef al., 2002).
1.2 Brain tumor
Primary tumors of the central nervous system account for less then 1.5% of
all the cancer cases reported in the United States each year. According to
the Malaysian national cancer registry in 2002, brain cancer incidence per
100,000 populations is 2.3 in males and 1.7 in female.
2These infrequent tumors are the third leading cause of cancer-related deaths
among men 15-54 years of age and fourth leading cause of death for women
15-34 years of age. Moreover, primary brain tumors are the most common
solid tumor of childhood and the second leading cause of cancer death in
children after leukemia (Kilic et al., 2000).
Pathological approaches have shown that at the time of the initial diagnosis,
most malignant glioma tumors have spread more then 15 mm over the area
that can be identified by magnetic resonance imaging (MRI) scan (Kelly et
al., 1987, Greene et al., 1989). Several molecular mechanisms are involved
in the development of gliomas and their progression to more malignant
tumors. For instance, the progression to higher grade glioma is associated
with inactivation of the p53 tumor suppression gene on chromosome 17p, as
well as over-expression of platelet-derived growth factor (PDGF) (Dunn et al.,
2000). Furthermore, progression to glioblastoma involves amplification of
epidermal growth factor receptor (EGFR), murine double minute 2 (MDM2)
genes and the expression of angiogenic factors such as vascular endothelial
growth factor (VEGF) (Schlegel et al., 1994, Biernat, et al., 1997).
The prognosis for people affected by these rapidly growing tumors is
currently very poor. Therapeutic modalities for malignant gliomas, including
surgery, radiation and chemotherapy are of limited effectiveness and novel
treatment modalities must be explored.
3A direct targeting of cytotoxicity agents to cancer cells represents a modern
approach to the treatment of malignant glioma and other cancers, because it
should improve tumor inhibition and decrease toxicity.
1.3 Nitrogen-sulphur Donor Ligands
Coordination compounds are molecules containing coordinate bonding where
ligands have excess electrons and can form coordinate linkages upon
interaction with metal centers. The ligands may be neutral molecules or ions.
Ligands are attached to the central atom by dative bonds or coordinate
covalent bonds. In an ordinary covalent bond, each of the bonded atoms
contributes one electron to the electron pair that forms the bond. The
coordinating atom or ligand, called the donor, donates a pair of electrons to
the central atom, called the acceptor. Proceeding from the donor atom to the
acceptor atom often depicts the bond. Interaction between metal ions and
ligands results in the formation of complexes. The entire aggregate of central
atom and ligands is generally called a complex.
The study of nitrogen-sulfur donor ligands continues to be of great interest to
researchers. Dithiocarbazate, NH2NHCS2 and its substituted derivatives have
received considerable attention over the past few decades (Tarafder and
Roy, 1988). The chemistry of such ligands warrants further study because
dithiocarbazic acid and the Schiff bases derived from its S-alkyl esters form
an interesting series of ligands whose properties can be greatly modified by
introducing organic substituents into the ligand molecules thereby inducing
different stereochemistry in the resultant metal complexes.
4The synthesis of the ligands and metal complexes are of interest because of
the intriguing observation that different ligands show different biological
properties, although they differ only slightly in their molecular structures (Ali
et a/., 1987; Majumder et al., 1988).
Transition metal complexes of these ligands are widely studied because of
their potential for therapeutic use (Tarafder and Roy 1988; Ali et al., 1996).
For example, the Schiff base of 2-benzoylpyridine with S-
methyldithiocarbazate (SMDTC) inhibits the growth of bacteria Escherichia
coli and Staphylococcus aureus to some extent while that with S-
benzyldithiocarbazate (SBDTC) shows no effect at all on the two mentioned
bacteria (Gou et al., 1990). The bioactivities of the ligands and the metal
complexes such as cytotoxicity, antimicrobial and anticancer activities have
not yet been widely studied. The mode of interaction of these compounds
with the cancer cells and microbes are yet to be investigated.
In the present study, the anticancer effects of newly synthesized pure
compounds on glioma cell lines, A172, U-87MG and T98G cell lines were
investigated. Besides, screening these compounds as potential novel anti-
cancer drugs for glioma, this study also investigates the mechanism involved,
including the study on apoptosis, gene expression, cell cycle and genotoxic
activity.
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1.4 Significance of the present study
This project is of great importance due to the fact that some of the studied
compounds are essentially new and no studies have been performed to
investigate the action of these compounds toward cancer cells other than
initial screening. It is anticipated that these compounds will open up many
interesting avenues for further research. In other words, this project will give
a new dimension to this field of brain cancer research and possibly by
carrying out further studies on these new compounds, more information in
this field will be gathered. This information may also enable further studies,
for instance anticancer activities of related compounds. A number of
compounds were tested (AR28, SB02 SPDRC, SMDCT, SBOTC, SMDB-Zn,
SMDB-Pt, SBD4-Cd, SBD4-Pt, SBD4-Zn and SMDB-Cd) using cytotoxicity
assay. SMDB-Cd and SMDB-Zn were found to be the most effective and
hence were focused in this study. The Schiff bases and their metal
complexes used in this study were synthesized and characterized by
elemental analyses and various physico-chemical techniques (Chew et a/.,
2004).
6Objectives:
The objectives of this study were:
1. To study the cytotoxic effects of the pure synthetic compounds,
(AR28, SB02 SPORC, SMDCT, SBOTC, SMOB-Zn, SMOB-Pt, SBD4-
Cd, SB04-Pt, SB04-Zn and SMOB-Cd) on glioma cell lines, A172,
U-87MG and T98G.
2. To study the effect of the most effective compounds on the expression
of EGFR and MOM2 genes.
3. To observe the morphology of the treated glioma cell lines by staining
using fluorescence and light microscopy and to quantitatively
determine apoptosis using tunnel assay.
4. To study the effect of the pure synthetic compounds on the cell cycle
by using flow cytometry.
5. To study the mechanism of apoptosis induction by the compounds in
glioma cells by determining caspase 8 and 9 activation.
6. To investigate the genotoxic effect of the compounds in CHO cells
using comet assay and measuring the DNA damage using CASP
software.
